Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE | 3,494 | reported | 03 Mar 2026 | tx 10+583,070−10,840 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Mar 2026 | EXERCISE | Viridian Therapeutics, Inc.\DE | 5,169 | — | |
| 03 Mar 2026 | TAX_WITHHOLDING | Viridian Therapeutics, Inc.\DE | 1,724 | 29.32 USD | |
| 02 Mar 2026 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 119,300 | 0.00 USD | deriv |
| 03 Mar 2026 | EXERCISE | Viridian Therapeutics, Inc.\DE | 5,169 | 0.00 USD | deriv |
| 02 Mar 2026 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 23,850 | 0.00 USD | deriv |
| 31 Dec 2025 | SALE | Viridian Therapeutics, Inc.\DE | 2,272 | 31.16 USD | |
| 03 Mar 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 20,679 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 124,072 | 0.00 USD | deriv |
| 12 Feb 2024 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 290,000 | 0.00 USD | deriv |